The primary goal of the Next-generation Technologies for Next-generation Cancer Models program (RFA CA-19-055) is to facilitate the use of the Human Cancer Models Initiative’s next generation cancer models (NGCMs) by the research community. The new tools and broader use of NGCMs will contribute to the progress in understanding the important pathways in cancer initiation, progression and metastasis, identification of mechanisms of resistance, novel therapeutic targets, development of diagnostic and/or predictive biomarkers, and other aspects relevant to precision oncology. Protocols, knowledge and materials developed by the program will be shared broadly and expeditiously with the research community.

Last updated: December 03, 2020